User profiles for M K Gibson
Molly GibsonFlagship Pioneering Verified email at flagshippioneering.com Cited by 6480 |
Gastric cancer, version 2.2022, NCCN clinical practice guidelines in oncology
…, P Fanta, F Farjah, H Gerdes, MK Gibson… - Journal of the National …, 2022 - jnccn.org
Gastric cancer is the third leading cause of cancer-related deaths worldwide. Over 95% of
gastric cancers are adenocarcinomas, which are typically classified based on anatomic …
gastric cancers are adenocarcinomas, which are typically classified based on anatomic …
[HTML][HTML] Oesophageal carcinoma
A Pennathur, MK Gibson, BA Jobe, JD Luketich - The Lancet, 2013 - thelancet.com
Oesophageal carcinoma affects more than 450 000 people worldwide and the incidence is
rapidly increasing. Squamous-cell carcinoma is the predominant form of oesophageal …
rapidly increasing. Squamous-cell carcinoma is the predominant form of oesophageal …
Bacterial phylogeny structures soil resistomes across habitats
Ancient and diverse antibiotic resistance genes (ARGs) have previously been identified
from soil 1 , 2 , 3 , including genes identical to those in human pathogens 4 . Despite the …
from soil 1 , 2 , 3 , including genes identical to those in human pathogens 4 . Despite the …
Longitudinal analysis of microbial interaction between humans and the indoor environment
The bacteria that colonize humans and our built environments have the potential to influence
our health. Microbial communities associated with seven families and their homes over 6 …
our health. Microbial communities associated with seven families and their homes over 6 …
Improved annotation of antibiotic resistance determinants reveals microbial resistomes cluster by ecology
Antibiotic resistance is a dire clinical problem with important ecological dimensions. While
antibiotic resistance in human pathogens continues to rise at alarming rates, the impact of …
antibiotic resistance in human pathogens continues to rise at alarming rates, the impact of …
[HTML][HTML] Pembrolizumab for platinum-and cetuximab-refractory head and neck cancer: results from a single-arm, phase II study
…, L Wirth, A Sukari, H Kang, MK Gibson… - Journal of Clinical …, 2017 - ncbi.nlm.nih.gov
Purpose There are no approved treatments for recurrent/metastatic head and neck squamous
cell carcinoma refractory to platinum and cetuximab. In the single-arm, phase II KEYNOTE-…
cell carcinoma refractory to platinum and cetuximab. In the single-arm, phase II KEYNOTE-…
Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the …
MK Gibson, Y Li, B Murphy, MHA Hussain… - Journal of Clinical …, 2005 - ascopubs.org
Purpose To determine the response rate, survival and toxicity of infusional cisplatin plus
fluorouracil (CF) versus cisplatin plus paclitaxel (CP) in patients with incurable squamous cell …
fluorouracil (CF) versus cisplatin plus paclitaxel (CP) in patients with incurable squamous cell …
Developmental dynamics of the preterm infant gut microbiota and antibiotic resistome
MK Gibson, B Wang, S Ahmadi, CAD Burnham… - Nature …, 2016 - nature.com
Abstract Development of the preterm infant gut microbiota is emerging as a critical research
priority 1. Since preterm infants almost universally receive early and often extended …
priority 1. Since preterm infants almost universally receive early and often extended …
Abrogation of p53-induced apoptosis by the hepatitis B virus X gene
The p53 tumor suppressor gene product is a transcriptional transactivator and a potent
apoptotic inducer. The fact that many of the DNA tumor virus oncoproteins bind to p53 and affect …
apoptotic inducer. The fact that many of the DNA tumor virus oncoproteins bind to p53 and affect …
Esophagectomy for T1 esophageal cancer: outcomes in 100 patients and implications for endoscopic therapy
…, PF Ferson, WE Gooding, MK Gibson… - The Annals of thoracic …, 2009 - Elsevier
OBJECTIVES: Esophagectomy is the standard treatment for T1 esophageal cancer (EC).
Interest in endoscopic therapies, particularly for T1 EC, is increasing. We evaluated the long-…
Interest in endoscopic therapies, particularly for T1 EC, is increasing. We evaluated the long-…